MediLink Therapeutics

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

France protests trigger 1,800 arrests as Macron faces nationwide crisis

Editorial infographic showing humanoid and industrial robots in a warehouse, with digital-twin mapping and key figures on commissioning, picking accuracy, operating hours and robotics orders.

Can physical AI escape the demo stage and become real industrial infrastructure?

Modal Labs has secured $750 million in Series D funding at a $15.75 billion valuation, marking a nearly 239% valuation surge in five months as demand for AI inference, GPU cloud infrastructure and autonomous coding agents accelerates, pushing the company's annualized run rate beyond $1 billion. Representative image.

Modal valuation jumps 239% as AI infrastructure demand drives $750m Series D

Salad and Go is coming back after bankruptcy, but competitors bought most of its old drive-thru network

Roche’s $570m MediLink bet gets Phase III validation as Tam-Peli cuts small-cell lung cancer death risk by 54%

MediLink Therapeutics' Tam-Peli improved median survival to 13.3 months from 9.4 months in relapsed small-cell lung cancer, giving Roche stronger clinical support for a programme that already carries $570 million of upfront and near-term economics.

bySrinath

September 14, 2026

MediLink Therapeutics, BioNTech expand partnership with new $1.8bn agreement

MediLink Therapeutics (Suzhou) Co., Ltd., a prominent clinical-stage biotech company, has entered into a significant new strategic collaboration…

byPallavi Madhiraju

May 28, 2024

The Latest

France protests trigger 1,800 arrests as Macron faces nationwide crisis

Can physical AI escape the demo stage and become real industrial infrastructure?

Salad and Go is coming back after bankruptcy, but competitors bought most of its old drive-thru network

Roche’s $570m MediLink bet gets Phase III validation as Tam-Peli cuts small-cell lung cancer death risk by 54%

MediLink Therapeutics, BioNTech expand partnership with new $1.8bn agreement

France protests trigger 1,800 arrests as Macron faces nationwide crisis

Can physical AI escape the demo stage and become real industrial infrastructure?

Salad and Go is coming back after bankruptcy, but competitors bought most of its old drive-thru network

Patient volumes rose 10% at Montrose Regional Health, so why are 77 positions disappearing?

Royal Mail wants 2,500 fewer support roles. Can it afford a frontline retention problem too?

Emergent’s Q2 adjusted EBITDA hit $96.5m, so what does its CFO successor inherit?

Rath AG nearly erased its first-half loss. Why is it now closing two European factories?